1370418129533304839

At Gamida, we are working to address the limitations of #bonemarrowtransplant treatment with the development of our investigational therapy, #omidubicel. Hear from our CMO, Ronit Simantov, M.D., on how we are looking to change the treatment paradigm: https://t.co/1omj6TlVXj https://t.co/LcoLQnusqk

Send us a message